351 related articles for article (PubMed ID: 27811204)
21. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
Wollert KC; Kempf T; Peter T; Olofsson S; James S; Johnston N; Lindahl B; Horn-Wichmann R; Brabant G; Simoons ML; Armstrong PW; Califf RM; Drexler H; Wallentin L
Circulation; 2007 Feb; 115(8):962-71. PubMed ID: 17283261
[TBL] [Abstract][Full Text] [Related]
23. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
[TBL] [Abstract][Full Text] [Related]
24. Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy.
Hilvo M; Wallentin L; Ghukasyan Lakic T; Held C; Kauhanen D; Jylhä A; Lindbäck J; Siegbahn A; Granger CB; Koenig W; Stewart RAH; White H; Laaksonen R;
J Am Heart Assoc; 2020 May; 9(10):e015258. PubMed ID: 32375553
[TBL] [Abstract][Full Text] [Related]
25. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
26. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Inflammatory Biomarkers in Outpatients With Prior Myocardial Infarction.
Minamisawa M; Motoki H; Izawa A; Kashima Y; Hioki H; Abe N; Miura T; Ebisawa S; Miyashita Y; Koyama J; Ikeda U
Int Heart J; 2016; 57(1):11-7. PubMed ID: 26742699
[TBL] [Abstract][Full Text] [Related]
28. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
[TBL] [Abstract][Full Text] [Related]
29. Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease.
Wollert KC; Kempf T; Wallentin L
Clin Chem; 2017 Jan; 63(1):140-151. PubMed ID: 28062617
[TBL] [Abstract][Full Text] [Related]
30. GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
Martinez CH; Freeman CM; Nelson JD; Murray S; Wang X; Budoff MJ; Dransfield MT; Hokanson JE; Kazerooni EA; Kinney GL; Regan EA; Wells JM; Martinez FJ; Han MK; Curtis JL;
Respir Res; 2017 Feb; 18(1):42. PubMed ID: 28245821
[TBL] [Abstract][Full Text] [Related]
31. Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.
Dubin R; Li Y; Ix JH; Shlipak MG; Whooley M; Peralta CA
Am Heart J; 2012 Feb; 163(2):274-9. PubMed ID: 22305847
[TBL] [Abstract][Full Text] [Related]
32. Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease.
Vedin O; Hagström E; Östlund O; Avezum A; Budaj A; Flather MD; Harrington RA; Koenig W; Soffer J; Siegbahn A; Steg PG; Stewart RAH; Wallentin L; White HD; Held C;
Int J Cardiol; 2017 Oct; 245():271-276. PubMed ID: 28735759
[TBL] [Abstract][Full Text] [Related]
33. GDF-15 (Growth Differentiation Factor 15) Is Associated With Hospitalization and Mortality in Patients With a Fontan Circulation.
Meyer SL; Wolff D; Ridderbos FS; Eshuis G; Hillege H; Willems TP; Ebels T; van Melle JP; Berger RMF
J Am Heart Assoc; 2020 May; 9(10):e015521. PubMed ID: 32384007
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
[TBL] [Abstract][Full Text] [Related]
35. Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: A prospective study.
Bao X; Borné Y; Xu B; Orho-Melander M; Nilsson J; Melander O; Engström G
Am Heart J; 2021 Apr; 234():81-89. PubMed ID: 33421373
[TBL] [Abstract][Full Text] [Related]
36. Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACS.
Zelniker TA; Jarolim P; Silverman MG; Bohula EA; Park JG; Bonaca MP; Scirica BM; Morrow DA
Clin Chem Lab Med; 2019 Jun; 57(7):1084-1092. PubMed ID: 30710475
[TBL] [Abstract][Full Text] [Related]
37. Growth differentiation factor 15 predicts cardiovascular events in stable coronary artery disease.
Wang J; Han LN; Ai DS; Wang XY; Zhang WJ; Xu XR; Liu HB; Zhang J; Wang P; Li X; Chen ML
J Geriatr Cardiol; 2023 Jul; 20(7):527-537. PubMed ID: 37576485
[TBL] [Abstract][Full Text] [Related]
38. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
[TBL] [Abstract][Full Text] [Related]
39. Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study.
Rohatgi A; Patel P; Das SR; Ayers CR; Khera A; Martinez-Rumayor A; Berry JD; McGuire DK; de Lemos JA
Clin Chem; 2012 Jan; 58(1):172-82. PubMed ID: 22065155
[TBL] [Abstract][Full Text] [Related]
40. GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction.
Skau E; Henriksen E; Wagner P; Hedberg P; Siegbahn A; Leppert J
Eur J Prev Cardiol; 2017 Oct; 24(15):1576-1583. PubMed ID: 28762762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
